Molecular Markers For Guiding Colorectal Cancer Therapy - By Bert O'neil, Md

Molecular Markers for Guiding Colorectal Cancer Therapy - by Bert O'Neil, MD

The Society for Translational Oncology

Molecular Markers for Guiding Colorectal Cancer Therapy

Dr. O'Neil Discusses the Development of Biomarkers for CRC

Dr. O'Neil on Left-Sided Versus Right-Sided CRC

Dr. O'Neil on Stemness Inhibitors for CRC Treatment

Molecular Biomarkers for the Evaluation of Colorectal Cancer

Molecular Profiling in Colorectal Cancer

Colon Cancer Metastases

How and Why Oncologists Look for Molecular Markers

Bert O’Neill, MD, on making immunotherapy more effective in mCRC

Bert O'Neil, MD on the importance of choosing mCRC treatment based on primary tumor site

Bert O'Neil, MD on integrating regorafenib and trifluridine into later lines of mCRC treatment

Colon Cancer Diagnosis

Role of Molecular Testing in CRC Management

Molecular Assays for Colorectal Cancer Care - William Grady, MD

Using molecular markers to target therapy

SAGES - Minimally Invasive Surgery Videos

Molecular Testing in Colorectal Cancer

Bert O'Neil, MD discusses decision making based on toxicities factor for later lines of mCRC therapy